Eight weeks of MitoQ supplementation does not alter kidney function or urinary kidney injury biomarkers in middle-aged and older adults. | ClinicLens
Several human trials have used the mitochondrial antioxidant mitoquinol mesylate (MitoQ). There are no apparent negative consequences on the kidneys following an acute high dose of MitoQ in young adults; however, it remains unclear whether chronic MitoQ influences kidney function
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.